WeedMD and Privately Owned CannTx Life Sciences Sign Letter of Intent to Create a Cannabis Cultivation and Consumer-Centric Product Portfolio

  • Strategic acquisition of innovative, specialized cannabis operator will fold in micro-propagation technology, a craft portfolio, and solventless extraction capabilities
  • Complementary operations and combined brand portfolio meets emerging trends in consumer preference, alongside continued growth in new business verticals
  • Guelph-based state-of-the-art facility will help create synergies and further cost efficiencies to bring new strains and high-margin products to market at greater scale and consistency…

Click here to view the original article.